- Young biotech stock (IPO-ed in 2022) - Broke out from IPO base back in Jan, and now building a tight pennant - Biotechs IBBXBILABU are acting right as a sector
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.